GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » EV-to-EBITDA

StemRIM (TSE:4599) EV-to-EBITDA : 106.68 (As of May. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, StemRIM's enterprise value is 円19,338 Mil. StemRIM's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was 円181 Mil. Therefore, StemRIM's EV-to-EBITDA for today is 106.68.

The historical rank and industry rank for StemRIM's EV-to-EBITDA or its related term are showing as below:

TSE:4599' s EV-to-EBITDA Range Over the Past 10 Years
Min: -80.22   Med: -22.96   Max: 360.27
Current: 106.67

During the past 7 years, the highest EV-to-EBITDA of StemRIM was 360.27. The lowest was -80.22. And the median was -22.96.

TSE:4599's EV-to-EBITDA is ranked worse than
93.42% of 456 companies
in the Biotechnology industry
Industry Median: 10.52 vs TSE:4599: 106.67

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), StemRIM's stock price is 円464.00. StemRIM's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was 円2.932. Therefore, StemRIM's PE Ratio for today is 158.25.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


StemRIM EV-to-EBITDA Historical Data

The historical data trend for StemRIM's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM EV-to-EBITDA Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
EV-to-EBITDA
Get a 7-Day Free Trial - 97.28 -54.21 -21.63 211.67

StemRIM Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.00 203.05 211.67 137.65 135.50

Competitive Comparison of StemRIM's EV-to-EBITDA

For the Biotechnology subindustry, StemRIM's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemRIM's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where StemRIM's EV-to-EBITDA falls into.



StemRIM EV-to-EBITDA Calculation

StemRIM's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=19337.991/181.279
=106.68

StemRIM's current Enterprise Value is 円19,338 Mil.
StemRIM's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円181 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemRIM  (TSE:4599) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

StemRIM's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=464.00/2.932
=158.25

StemRIM's share price for today is 円464.00.
StemRIM's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2.932.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


StemRIM EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of StemRIM's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


StemRIM (TSE:4599) Business Description

Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines